S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
ETR:MUV2

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MUV2) Stock Price, News & Analysis

€409.10
-1.90 (-0.46%)
(As of 04/17/2024 ET)
Today's Range
€409.10
€416.30
50-Day Range
€400.70
€453.60
52-Week Range
€318.80
€454.10
Volume
272,721 shs
Average Volume
732,414 shs
Market Capitalization
$55.06 billion
P/E Ratio
12.08
Dividend Yield
3.67%
Price Target
N/A
MUV2 stock logo

About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock (ETR:MUV2)

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market. The company also provides property and casualty reinsurance solutions, including agricultural risk, data analytics, infrastructure risk profiler, property insurance, retroactive reinsurance, insurance linked securities, location risk, risk transfer, and cyber, NatCatSERVICE for natural catastrophe loss database, REALYTIX ZERO, IMPROVEX, and cert2go, as well as consulting services for reinsurance, business advisory, portfolio performance and management, claims management, commercial motor, telematics, and electric vehicles. In addition, the company provides solutions for industry clients, such as IoT cover, earnings quality insurance protection, captive insurance and risk transfer, liability, weather risks, space and satellite insurance, solar and biomass insurance, wind insurance, digital asset, mining risks cover, construction projects covers and services, aviation insurance, power and utilities, industrial cyber insurance, risk suite, location risk intelligence, digital risks, PV warranty insurance, parametric, Insure AI, e-mobility, circular economy, liquidation damage cover, and natural catastrophes solutions. Further, it offers life, property-casualty, health, legal protection, and travel insurance products under the ERGO brand name; and insurance solutions for agriculture, captive, epidemic, cyber, and renewable energy. The company was founded in 1880 and is based in Munich, Germany.

MUV2 Stock Price History

MUV2 Stock News Headlines

Munich Re 4Q Profit Fell, Beat Expectations
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Munich Re Raises Guidance After 3Q Profit Beat Forecasts
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
EG vs. MURGY: Which Stock Is the Better Value Option?
12 Biggest Health Insurance Companies in the World
Activist Jeff Ubben discovers a ‘jewel’ at Bayer
See More Headlines
Receive MUV2 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Insurance - Reinsurance
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
42,812
Year Founded
N/A

Profitability

Net Income
$4.61 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$58.61 billion
Cash Flow
€77.36 per share
Book Value
€220.27 per share

Miscellaneous

Free Float
N/A
Market Cap
$55.06 billion
Optionable
Not Optionable
Beta
0.82
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Joachim Wenning (Age 59)
    Chairman of Management Board
    Comp: $4.43M
  • Dr. Christoph Jurecka (Age 50)
    CFO & Member of Management Board
    Comp: $3.11M
  • Dr. Thomas Blunck (Age 59)
    Member of Management Board
    Comp: $1.95M
  • Mr. Nicholas J. Gartside C.F.A. (Age 49)
    Chief Investment Officer & Member of Management Board
    Comp: $1.95M
  • Dr. Achim Kassow (Age 58)
    Labour Relations Director & Member of Management Board
    Comp: $1.95M
  • Mr. Stefan Heinrich Golling (Age 47)
    Member of Management Board
    Comp: $1.95M
  • Ms. Clarisse Kopff
    Member of Management Board
  • Dr. Torsten Jeworrek (Age 63)
    Chief Executive Officer of Reinsurance Business
    Comp: $2.9M
  • Dr. Markus Riess (Age 58)
    Head of Economics, Sustainability & Public Affairs and Member of Management Board
    Comp: $3.78M
  • Ms. Mari Lizette Malherbe
    Member of Management Board

Should I Buy Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock? MUV2 Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Münchener Rückversicherungs-Gesellschaft Aktienges:

  • Recent positive financial reports indicate strong performance and potential growth.
  • Strategic partnerships with key industry players enhancing market position.
  • Introduction of innovative insurance products tailored to current market demands.
  • Current stock price is undervalued compared to industry peers, presenting a buying opportunity.
  • Consistent dividend payouts providing income stability for investors.

Cons

Investors should be bearish about investing in Münchener Rückversicherungs-Gesellschaft Aktienges for these reasons:

  • Market volatility and economic uncertainties could impact the company's financial performance.
  • Regulatory changes in the insurance sector may pose challenges for the company's operations.
  • Increased competition leading to potential pressure on profit margins.
  • Exposure to catastrophic events could result in significant claims payouts affecting profitability.
  • Currency exchange rate fluctuations may impact international business operations.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München pros and cons to contact@marketbeat.com.

MUV2 Stock Analysis - Frequently Asked Questions

How have MUV2 shares performed in 2024?

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München's stock was trading at €375.10 at the beginning of 2024. Since then, MUV2 shares have increased by 9.1% and is now trading at €409.10.
View the best growth stocks for 2024 here
.

Is Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München a good dividend stock?

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (ETR:MUV2) pays an annual dividend of €15.00 per share and currently has a dividend yield of 3.33%. The dividend payout ratio is 44.29%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München investors own include Covestro (1COV), Basf (BAS), Heidelberg Materials (HEI), Volkswagen (VOW3), Agilent Technologies (A), Alcoa (AA), Advance Auto Parts (AAP), AbbVie (ABBV), Ambev (ABEV).

This page (ETR:MUV2) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners